Physician profile
Jonathan Wong
NPI 1780926808
$2,738.04
in general payments reported to CMS, 2019-2025
17 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $293 · 2021: $150 · 2022: $59.08 · 2023: $171 · 2024: $178 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $768.88 | 2019-2025 | Triclip, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $465.97 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.08 | 2020 | |
| Edwards Lifesciences Corporation | $237.48 | 2024-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $228.13 | 2019-2025 | Sentinel |
| Astrazeneca Pharmaceuticals LP | $136.94 | 2019-2021 | |
| Abiomed | $125.41 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $85.40 | 2024 | |
| Alnylam Pharmaceuticals INC. | $75.82 | 2019 | |
| Gilead Sciences, INC. | $68.28 | 2019 | |
| Atricure, INC. | $58.12 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.34 | 2021 | |
| Sanofi-Aventis U.S. LLC | $44.31 | 2019 | |
| Pfizer INC. | $42.00 | 2019 | |
| Astellas Pharma US INC | $38.11 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $36.80 | 2025 | Cleviprex |
| Bardy Diagnostics, INC. | $20.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.